Recent publications from the Alzheimer's Disease Neuroimaging Initiative: Reviewing progress toward improved AD clinical trials
Abstract
The Alzheimer's Disease Neuroimaging Initiative (ADNI) has continued development and standardization of methodologies for biomarkers and has provided an increased depth and breadth of data available to qualified researchers. This review summarizes the over 400 publications using ADNI data during 2014 and 2015.
Document Details
- Document Type
- Pub Defense Publication
- Publication Date
- Mar 22, 2017
- Source ID
- 10.1016/j.jalz.2016.11.007
Entities
People
- Andrew J. Saykin
- Arthur W. Toga
- Clifford Jack
- Dallas P. Veitch
- Danielle Harvey
- John C. Morris
- John Q. Trojanowski
- Laurel A. Beckett
- Leslie M. Shaw
- Michael W. Weiner
- Nigel J. Cairns
- Paul S. Aisen
- Robert C. Green
- Ronald C. Petersen
- The Alzheimer’s Disease Neuroimaging Initiative*
- William J. Jagust
Organizations
- AstraZeneca
- Biogen
- Eli Lilly and Company
- Geneva University Hospitals
- Harvard Medical School
- Helen Wills Neuroscience Institute
- Indiana University
- Loma Linda University Medical Center
- Mayo Clinic
- National Institute of Justice
- National Institute of Neurological Disorders and Stroke
- National Institute on Aging
- Novartis
- Office of Legacy Management
- Pfizer
- Siemens
- Tohoku University
- United States Department of Defense
- United States Department of Veterans Affairs
- University of California
- University of California, Davis
- University of California, San Francisco
- University of Pennsylvania
- University of Southern California
- Washington University in St. Louis